Collagen alpha chain (None; scientific literature may use abbreviations such as COL1A1, COL1A2, COL6A3, etc. to name specific alpha chains, but for the general term "Collagen alpha chains," no standard abbreviation exists[2][3][8].)
Target
None; scientific literature may use abbreviations such as COL1A1, COL1A2, COL6A3, etc. to name specific alpha chains, but for the general term "Collagen alpha chains," no standard abbreviation exists[2][3][8].
Molecular classification
Other (structural subunit of extracellular matrix proteins), Component of fibrillar protein family (when specified, e.g., "Type I collagen alpha chain"), Not a receptor, enzyme, transporter, or transcription factor
01
Overview
Collagen alpha chains are the individual polypeptide subunits that combine to form the characteristic triple-helical structure of collagen molecules, known as tropocollagen[3][8]. Each collagen triple helix is formed by either identical or distinct alpha chains, depending on the collagen type: for example, type I collagen consists of two alpha-1(I) chains and one alpha-2(I) chain, while type II collagen is made from three alpha-1(II) chains[1][5][8]. There are dozens of different collagen alpha chains encoded by separate genes (e.g., COL1A1, COL6A3), which assemble with strict specificity to form various collagen types throughout the body[3][8]. Collagen alpha chains play essential roles in tissue architecture, strength, elasticity, and development[1][3][4]. Some specific alpha chains, such as collagen alpha-3 (VI) chain, also have unique functions as disease biomarkers and regulators of cellular behavior, especially in cancer and fibrosis via secreted fragments like endotrophin[2][4]. However, the general term "collagen alpha chains" is too broad and unspecific to serve as a conventional drug target or molecular entity for therapeutic intervention[2][3][8].
Other names
Collagen alpha polypeptideCollagen alpha subunitPrecursor collagen chainCollagen α chaine.g., COL1A1 (collagen type I alpha 1 chain)COL6A3 (collagen type VI alpha 3 chain)
02
Mechanism of action
Not applicable (as "collagen alpha chains" is not a therapeutic target); in specific instances, drugs may degrade collagen fibrils or inhibit fibrosis through enzymatic mechanisms[1][2].
03
Biological functions
Structural support in extracellular matrix[1][3][7][8]Formation of collagen triple helix structure[5][8]Tissue strength and elasticity (as part of collagen)[3]Cell adhesion and migration (when referring to certain chains, e.g., alpha-3 (VI) via endotrophin in cancer)[2]Role in organ development (as part of collagen)[3][4]
04
Disease associations
Cancer (especially for COL6A3, alpha-3 (VI) chain, via endotrophin's role in tumor progression)[2]Fibrosis and tissue scarring (as part of general collagen involvement)[2][4]Connective tissue disorders (when mutations occur in specific alpha chains)[4]Inflammatory diseases (e.g., atopic dermatitis involving COL6A5)[4]Skeletal disorders (mutations in chains of types I, II, X, XXVII, etc.[4])Other (depends on the specific alpha chain — some are biomarkers in kidney disease, bone disorders, cartilage degeneration[4])
05
Safety considerations
None for "collagen alpha chains" as an isolated entity; general concerns for collagen-targeting drugs include immune reactions, excessive tissue breakdown, interference with tissue integrity, and impaired wound healing[2][4].Excessive degradation or modification of collagen (which involves its alpha chains) can lead to tissue weakness, scarring, or impaired organ function[1][3][4].
06
Interacting drugs
None specific for "collagen alpha chains" as a general entity; some drugs may interact with collagen (e.g., enzymatic collagenase, pepsin for research/clinical use[1]). Specific alpha chains (e.g., endpoints for anti-fibrotic therapies) may be assessed, but the alpha chain itself is not a drug target.
07
Biomarkers
Endotrophin (cleaved fragment of collagen alpha-3 (VI) chain, i.e., COL6A3, is a biomarker in cancer and metabolic diseases)[2]Type XXIV and type XXVII collagen alpha chains are markers of bone formation and cartilage calcification, respectively[4]
Beyond the preview
Go deeper on Collagen alpha chain (None; scientific literature may use abbreviations such as COL1A1, COL1A2, COL6A3, etc. to name specific alpha chains, but for the general term "Collagen alpha chains," no standard abbreviation exists[2][3][8].).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Collagen alpha chain (None; scientific literature may use abbreviations such as COL1A1, COL1A2, COL6A3, etc. to name specific alpha chains, but for the general term "Collagen alpha chains," no standard abbreviation exists[2][3][8].).